Skip to main content

Sexual Function in Untreated and Treated Hypertension

  • Chapter
  • First Online:
Special Issues in Hypertension
  • 1253 Accesses

Abstract

Sexual dysfunction is frequently encountered in hypertensive patients, affecting both patients’ and their partners’ quality of life. Hypertension induces structural and functional alterations in penile vessels, thereby inducing sexual dysfunction. Older antihypertensive drugs, such as beta-blockers and diuretics, exert negative effects on sexual function; newer agents, such as calcium antagonists and angiotensin-converting enzyme inhibitors, exert negative effects, while angiotensin receptor blockers and nebivolol might even exert beneficial effects on sexual function. These differences between antihypertensive agents must be taken into account when managing hypertension. The strong association between hypertension and sexual dysfunction and the impact on quality of life require special attention from all doctors and other health-care professionals treating hypertensive patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kearney PM, Whelton M, Raynolds K et al (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365:217–223

    PubMed  Google Scholar 

  2. Mancia G, De Backer G, Dominiczak A et al (2007) European society of cardiology. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). J Hypertens 25:1105–1187

    Article  PubMed  CAS  Google Scholar 

  3. Manolis AJ, Doumas M, Viigimaa M, Narkiewicz K (2011) Hypertension and sexual dysfunction. European Society of Hypertension Scientific Newsletter: Update on Hypertension Management 2007. 8 Updated on May 2011

    Google Scholar 

  4. Viigimaa M, Doumas M, Vlachopoulos C et al (2011) European society of hypertension working group on sexual dysfunction. Hypertension and sexual dysfunction: time to act. J Hypertens 29:403–407

    Article  PubMed  CAS  Google Scholar 

  5. Manolis A, Doumas M (2008) Sexual dysfunction: the ‘prima ballerina’ of hypertension-related quality-of-life complications. J Hypertens 26:2074–2084

    Article  PubMed  CAS  Google Scholar 

  6. Manolis A, Doumas M (2008) Hypertension and sexual dysfunction. Arch Med Sci 4:1–14

    Google Scholar 

  7. Edwards WM, Coleman E (2004) Defining sexual health: a descriptive overview. Arch Sex Behav 33:189–195

    Article  PubMed  Google Scholar 

  8. NIH Consensus Conference: Impotence (1993) NIH consensus development panel on impotence. JAMA 270:83–90

    Google Scholar 

  9. Bachman GA, Avci D (2004) Evaluation and management of female sexual dysfunction. Endocrinologist 14:337–345

    Article  Google Scholar 

  10. Douma S, Doumas M, Tsakiris A, Zamboulis C (2007) Male and female sexual dysfunction: Is hypertension an innocent bystander or a major contributor? Rev Bras Hypertens 14:139–147

    Google Scholar 

  11. Grimm RH Jr, Grandits GA, Prineas RJ et al (1997) Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of mild hypertension study (TOMHS). Hypertension 29:8–14

    Article  PubMed  CAS  Google Scholar 

  12. Doumas M, Douma S (2006) Sexual dysfunction in essential hypertension: myth or reality? J Clin Hypertens 8:269–274

    Article  Google Scholar 

  13. Duncan LE, Lewis C, Jenkins P, Pearson TA (2000) Does hypertension and its pharmacotherapy affect the quality of sexual function in women? Am J Hypertens 13:640–647

    Article  PubMed  CAS  Google Scholar 

  14. Doumas M, Tsiodras S, Tsakiris A et al (2006) Female sexual dysfunction in essential hypertension: a common problem being uncovered. J Hypertens 24:2387–2392

    Article  PubMed  CAS  Google Scholar 

  15. Gratzke C, Angulo J, Chitaley K et al (2010) Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med 7:445–475

    Article  PubMed  CAS  Google Scholar 

  16. Montorsi P, Ravagnani PM, Galli S et al (2005) The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol 96:19M–23M

    Article  PubMed  Google Scholar 

  17. Toblli JE, Stella I, Inserra F et al (2000) Morphological changes in cavernous tissue in spontaneously hypertensive rats. Am J Hypertens 13:686–692

    Article  PubMed  CAS  Google Scholar 

  18. Ushiyama M, Morita T, Kuramochi T et al (2004) Erectile dysfunction in hypertensive rats results from impairment of the relaxation evoked by neurogenic carbon monoxide and nitric oxide. Hypertens Res 27:253–261

    Article  PubMed  CAS  Google Scholar 

  19. Becker AJ, Uckert S, Stief CG et al (2001) Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence. Urology 57:193–198

    Article  PubMed  CAS  Google Scholar 

  20. Bechara AJ, Cao G, Casabé AR et al (2003) Morphological modifications in clitoris and vagina in spontaneously hypertensive rats. Int J Impot Res 15:166–172

    Article  PubMed  CAS  Google Scholar 

  21. Doumas M, Tsakiris A, Douma S et al (2006) Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects. J Androl 27:469–477

    Article  PubMed  Google Scholar 

  22. Doumas M, Douma S (2006) The effect of antihypertensive drugs on erectile function: a proposed management algorithm. J Clin Hypertens 8:359–364

    Article  CAS  Google Scholar 

  23. Toblli J, Stella I, Néstor Mazza O et al (2004) Protection of cavernous tissue in male spontaneously hypertensive rats. Beyond blood pressure control. Am J Hypertens 17:516–522

    Article  PubMed  Google Scholar 

  24. Toblli JE, Cao G, Casas G, Mazza ON (2006) In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats. Am J Hypertens 19:1226–1232

    Article  PubMed  CAS  Google Scholar 

  25. Fogari R, Zoppi A, Poletti L et al (2001) Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 14:27–31

    Article  PubMed  CAS  Google Scholar 

  26. Fogari R, Preti P, Derosa G et al (2002) Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol 58:177–180

    Article  PubMed  CAS  Google Scholar 

  27. Fogari R, Zoppi A, Corradi L et al (1998) Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am J Hypertens 11:1244–1247

    Article  PubMed  CAS  Google Scholar 

  28. Medical Research Council Working Party on mild to moderate hypertension, report of 1981 (1981) Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 2:539–543

    Google Scholar 

  29. Wassertheil-Smoller S, Blaufox MD, Oberman A et al (1991) Effect of antihypertensives on sexual function and quality of life: the TAIM study. Ann Intern Med 114:613–620

    PubMed  CAS  Google Scholar 

  30. Lindholm LH, Persson M, Alaupovic P et al (2003) Metabolic outcome during 1 year in newly detected hypertensives: results of the antihypertensive treatment and lipid profile in a north of Sweden efficacy evaluation (ALPINE study). J Hypertens 21:1563–1574

    Article  PubMed  CAS  Google Scholar 

  31. Böhm M, Baumhäkel M, Teo K et al (2010) Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessme Nt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation 121:1439–1446

    Article  PubMed  Google Scholar 

  32. Brixius K, Middeke M, Lichtenthal A et al (2007) Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol 34:327–331

    Article  PubMed  CAS  Google Scholar 

  33. Williams GH, Croog SH, Levine S et al (1987) Impact of antihypertensive therapy on quality of life: effect of hydrochlorothiazide. J Hypertens Suppl 5:S29–S35

    Article  PubMed  CAS  Google Scholar 

  34. Ko DT, Hebert PR, Coffey CS et al (2002) Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 288:351–357

    Article  PubMed  CAS  Google Scholar 

  35. Douma S, Doumas M, Petidis K et al. (2008) Beta blockers and sexual dysfunction: bad guys—good guys. In: Beta Blockers: New Research (eds) Momoka Endo and Narami Matsumoto. Nova Science Publishers Inc, pp 1–13

    Google Scholar 

  36. Silvestri A, Galetta P, Cerquetani E et al (2003) Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J 24:1928–1932

    Article  PubMed  CAS  Google Scholar 

  37. Cocco G (2009) Erectile dysfunction after therapy with metoprolol: the Hawthorne effect. Cardiology 112:174–177

    Article  PubMed  CAS  Google Scholar 

  38. Fogari R, Preti P, Zoppi A et al (2004) Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women. Am J Hypertens 17:77–81

    Article  PubMed  CAS  Google Scholar 

  39. Kostis JB, Jackson G, Rosen R et al (2005) Sexual dysfunction and cardiac risk (the second Princeton Consensus conference). Am J Cardiol 96:313–321

    Article  PubMed  Google Scholar 

  40. Dusing R (2003) Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press Suppl 12:29–34

    Article  Google Scholar 

  41. Della Chiesa A, Pfifner D, Meier B et al (2003) Sexual activity in hypertensive men. J Human Hypertens 17:515–521

    Article  CAS  Google Scholar 

  42. Llisterri JL, Lozano Vidal JV, Aznar Vicente J et al (2001) Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci 321:336–341

    Article  PubMed  CAS  Google Scholar 

  43. Doumas M, Tsakiris A, Douma S et al (2006) Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients. Asian J Androl 8:177–182

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Margus Viigimaa .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Italia

About this chapter

Cite this chapter

Viigimaa, M., Doumas, M. (2012). Sexual Function in Untreated and Treated Hypertension. In: Berbari, A., Mancia, G. (eds) Special Issues in Hypertension. Springer, Milano. https://doi.org/10.1007/978-88-470-2601-8_29

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2601-8_29

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2600-1

  • Online ISBN: 978-88-470-2601-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics